SCHEMBL1269948

SCHEMBL1269948

CC(C)S(=O)(=O)c1ccc(Sc2ccc(NS(=O)(=O)c3ccc(Cl)cc3Cl)nc2C(=O)C2CC2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGDR Q13258 1/20 0.38
▸ PTGDR2 Q9Y5Y4 1/20 0.38
▸ RORC P51449 1/20 0.36
▸ ABL1 P00519 1/20 0.36
▸ CCR4 P51679 1/20 0.34
▸ HSD11B1 P28845 1/20 0.33
▸ PIK3C3 Q8NEB9 2/20 0.33
▸ ITGA1 P56199 2/20 0.33
▸ EDNRA P25101 2/20 0.33
▸ PPARG P37231 3/20 0.33
▸ PPARD Q03181 3/20 0.33
▸ PPARA Q07869 3/20 0.33
▸ PIK3CD O00329 1/20 0.33
▸ PIK3CA P42336 1/20 0.33
▸ PIK3CB P42338 1/20 0.33
▸ PIK3CG P48736 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ BRAF P15056 1/20 0.33
▸ FLT1 P17948 1/20 0.32
▸ FLT4 P35916 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1269946 0.88 PTGDR2 (0.40) PTGDRPTGDR2CCR4HSD11B1PIK3C3
SCHEMBL1269951 0.87 PTGDR2 (0.41) PTGDRPTGDR2RORCCCR4HSD11B1
SCHEMBL1268967 0.87 PTGDR (0.36) PTGDRPTGDR2CCR4HSD11B1PIK3C3
SCHEMBL1269518 0.86 PTGDR (0.39) PTGDRPTGDR2HSD11B1
SCHEMBL1269493 0.86 HTT (0.38) PTGDRPTGDR2
SCHEMBL1269665 0.85 HTT (0.40) TP53
SCHEMBL1268561 0.85 PTGDR2 (0.42) PTGDRPTGDR2RORCHSD11B1PIK3C3
SCHEMBL1268682 0.84 KMT2A (0.43) —
SCHEMBL1268965 0.81 PIK3C3 (0.37) PTGDRPTGDR2RORCPIK3C3PPARG
SCHEMBL1269586 0.78 PIK3C3 (0.38) PTGDRPTGDR2HSD11B1PIK3C3PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
EP-1786782-B1 BISARYL-SULFONAMIDES AMGEN INC (US) 2010-03-31 — — EP disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-20060084802-A1 Bisaryl-sulfonamides AMGEN INC. 2006-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221584-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG PTGDR 709/4885PTGDR2 649/4885RORC 39/4885
US-20060084802-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG PTGDR 709/4885PTGDR2 649/4885RORC 39/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback